Mentice AB (publ) (STO: MNTC)

Market Cap	539.50M
Revenue (ttm)	276.06M
Net Income (ttm)	-23.28M
Shares Out	25.57M
EPS (ttm)	-0.91
PE Ratio	n/a
Forward PE	69.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,485
Open	21.40
Previous Close	21.10
Day's Range	21.00 - 21.60
52-Week Range	20.00 - 71.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Mentice AB

Mentice AB (publ) provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas. The company operates through three segments: Systems, Software Licenses and Service. It offers software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced, essential, and int...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 122
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2023, Mentice AB's revenue was 275.12 million, an increase of 25.39% compared to the previous year's 219.42 million. Losses were -2.82 million, -90.81% less than in 2022.